(Ala13)-Apelin-13
Based on 1 publication(s) in Google Scholar
(Ala13)-Apelin-13 is a potent apelin receptors (APJ) antagonist. (Ala13)-Apelin-13 inhibits gastric motility through vagal cholinergic pathway.
For research use only. We do not sell to patients.
- CAS No.: 568565-11-7
- Formula: C63H107N23O16S
- Molecular Weight:1474.73
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) (Ala13)-Apelin-13
More
Biological Activity
Description
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:250-300 g, Sprague-Dawley rats[1]
-
Dosage:1-300 pmol/60 nl
-
Administration:Microinjected into the DVC (dorsal vagal complex (DVC)
-
Result:Decreased gastric tone and motility in a dose-dependent manner with D50 ≈ 27 pmol for both antrum and corpus.
Chemical Information
-
CAS No. 568565-11-7
-
Molecular Weight 1474.73
-
Formula C63H107N23O16S
-
Sequence
Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Ala
-
Sequence Shortening
QRPRLSHKGPMPA
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Purity & Documentation
References
[1]. Bülbül M, et al. Apelin-13 inhibits gastric motility through vagal cholinergic pathway in rats. Am J Physiol Gastrointest Liver Physiol. 2018 Feb 1;314(2):G201-G210. [Content Brief]
[2]. O'Harte FPM,et al. Acylated apelin-13 amide analogues exhibit enzyme resistance and prolonged insulin releasing, glucose lowering and anorexic properties. Biochem Pharmacol. 2017 Dec 15;146:165-173. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)